admin
03-28-2004, 09:05 AM
The association requests that FDA approve a health based label for olive oil. In support of the request, the association has presented a scientific analysis which CRE is presenting for public comment.
Comments received will be reviewed and presented to FDA as a first step to ensure compliance with the Data Quality Act.
The petitioners conclude:
"In summary, the olive oil dietary intervention studies published since 1989 confirm the preliminary conclusions of the Diet and Health Report that MUFAs do not cause adverse effects on plasma HDL-C or TGs that often result from low-fat, high-carbohydrate diets. Seven of these studies found that olive-oil containing diets resulted in improved concentrations of T-C, LDL-C, HDL-C or Tgs compared to law-fat carbohydrate diets(Battio et. al.,1998: Garg et. al.
Read document
http://www.fda.gov/ohrms/dockets/dockets/03q0559/03Q-0559-01-QHC0001-01-VOL1.PDF
Comments received will be reviewed and presented to FDA as a first step to ensure compliance with the Data Quality Act.
The petitioners conclude:
"In summary, the olive oil dietary intervention studies published since 1989 confirm the preliminary conclusions of the Diet and Health Report that MUFAs do not cause adverse effects on plasma HDL-C or TGs that often result from low-fat, high-carbohydrate diets. Seven of these studies found that olive-oil containing diets resulted in improved concentrations of T-C, LDL-C, HDL-C or Tgs compared to law-fat carbohydrate diets(Battio et. al.,1998: Garg et. al.
Read document
http://www.fda.gov/ohrms/dockets/dockets/03q0559/03Q-0559-01-QHC0001-01-VOL1.PDF